Literature DB >> 10754162

Subclinical Cushing syndrome due to adrenocorticotropic hormone-independent macronodular adrenocortical hyperplasia: changes in plasma cortisol levels during long-term follow-up.

T Sasao1, N Itoh, Y Sato, A Takahashi, T Tsukamoto.   

Abstract

A 63-year-old man with bilateral adrenal tumors was treated for hypertension and diabetes mellitus. Endocrinologic examination during follow-up revealed the production of cortisol to be independent of the regulation of the hypothalamo-pituitary-adrenal axis. Therefore, he was diagnosed as having subclinical Cushing syndrome, and these tumors were removed. Adrenocorticotropic hormone-independent macronodular adrenal hyperplasia (AIMAH) was endocrinologically and histopathologically diagnosed. This is the first report demonstrating that endocrinologic changes of AIMAH can be observed during long-term follow-up.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10754162     DOI: 10.1016/s0090-4295(99)00381-7

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  3 in total

1.  Classification, diagnosis and treatment of ACTH-independent macronodular adrenal hyperplasia.

Authors:  Heng-Chuan Su; Jun Dai; Xin Huang; Wen-Long Zhou; Bao-Xing Huang; Wan-Li Cao; Fu-Kang Sun
Journal:  Can Urol Assoc J       Date:  2013 Sep-Oct       Impact factor: 1.862

Review 2.  Adrenal incidentalomas: surgical treatment in 28 patients and update of the literature.

Authors:  A B Porcaro; G Novella; V Ficarra; P Curti; S Z Antoniolli; H S Suangwoua; G Malossini
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

Review 3.  Hidden hypercortisolism: a too frequently neglected clinical condition.

Authors:  L Giovanelli; C Aresta; V Favero; M Bonomi; B Cangiano; C Eller-Vainicher; G Grassi; V Morelli; F Pugliese; A Falchetti; L Gennari; A Scillitani; L Persani; I Chiodini
Journal:  J Endocrinol Invest       Date:  2021-01-04       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.